Prognostic analysis for children with hepatoblastoma with lung metastasis: A single‐center analysis of 98 cases

To analyze the factors affecting the prognosis of hepatoblastoma (HB) with lung metastasis in children.

[1]  L. Brugières,et al.  Another point of view on 2017 PRETEXT , 2018, Pediatric Radiology.

[2]  Chuifeng Fan,et al.  Hepatoblastoma with pure fetal epithelial differentiation in a 10-year-old boy , 2018, Medicine.

[3]  Yukichi Tanaka,et al.  The role of pulmonary metastasectomy for hepatoblastoma in children with metastasis at diagnosis: Results from the JPLT-2 study. , 2017, Journal of pediatric surgery.

[4]  M. Rela,et al.  Multidisciplinary management of hepatoblastoma in children: Experience from a developing country , 2017, Pediatric blood & cancer.

[5]  D. Stearns,et al.  Hepatoblastoma in an 11-year-old , 2017, Medicine.

[6]  Yukichi Tanaka,et al.  Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration. , 2017, The Lancet. Oncology.

[7]  Yang Li,et al.  Multidisciplinary effort in treating children with hepatoblastoma in China. , 2016, Cancer letters.

[8]  G. Tiao,et al.  Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy. , 2016, Journal of pediatric surgery.

[9]  J. Feusner,et al.  Outcomes of Patients With Relapsed Hepatoblastoma Enrolled on Children’s Oncology Group (COG) Phase I and II Studies , 2016, Journal of pediatric hematology/oncology.

[10]  T. Hishiki,et al.  The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. , 2016, European journal of cancer.

[11]  E. Hiyama.  Pediatric hepatoblastoma: diagnosis and treatment. , 2014, Translational pediatrics.

[12]  Yukichi Tanaka,et al.  Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium , 2014, Modern Pathology.

[13]  E. Hiyama,et al.  Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy , 2014, Current opinion in pediatrics.

[14]  Yukichi Tanaka,et al.  International pediatric liver cancer pathological classification: current trend , 2013, International Journal of Clinical Oncology.

[15]  B. Morland,et al.  Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study , 2013, The Lancet. Oncology.

[16]  G. Perilongo,et al.  Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). , 2013, European journal of cancer.

[17]  R. Arora.  Outcomes of hepatoblastoma in the Indian context , 2012, Indian Pediatrics.

[18]  G. Perilongo,et al.  Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  D. Zurakowski,et al.  Effects of Neoadjuvant Chemotherapy on Hepatoblastoma: A Morphologic and Immunohistochemical Study , 2010, The American journal of surgical pathology.

[20]  S. Kondo,et al.  Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT , 2010, Pediatric Surgery International.

[21]  B. Morland,et al.  Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. , 2009, The New England journal of medicine.

[22]  Hyun-Young Kim,et al.  Clinical Characteristics and Prognosis of Pediatric Hepatocellular Carcinoma , 2005, World Journal of Surgery.

[23]  Ronald Brown.  Another point of view. , 2004, Journal of the American Dental Association.

[24]  H. Mugishima,et al.  Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma , 2003, Pediatric Surgery International.

[25]  J. Quinn,et al.  Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  G. Perilongo,et al.  Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. , 2000, European journal of cancer.

[27]  H. Lai,et al.  Hepatocellular carcinoma in children: clinical review and comparison with adult cases. , 1998, Journal of pediatric surgery.

[28]  D. V. von Schweinitz,et al.  Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. , 1997, European journal of cancer.

[29]  H. Sather,et al.  Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5‐fluorouracil) in the treatment of children with malignant hepatoma , 1982, Cancer.